Expert: US Drug Shortages May Not Be Associated With Problems in the Global Supply Chain

Andrew Mulcahy, PhD, a senior policy researcher at RAND Corporation, discusses a recent report that showed the drug shortages in the United States may not be associated with problems in the global supply chain.

Pharmacy Times interviewed Andrew Mulcahy, PhD, a senior policy researcher at RAND Corporation, to discuss a recent report that showed the drug shortages in the United States may not be associated with problems in the global supply chain.

During the interview, Mulcahy addresses how long drug shortages have been affecting the US, how the COVID-19 pandemic has impacted the US drug supply chain, how the US drug shortage has been impacting US health systems during the pandemic, what the report showed regarding the global supply chain’s connection with drug shortages in the US, and what some of the actual causes of the drug shortage in the US were found to be based on the data.